黄色视频不卡_午夜福利免费观看在线_亚洲国产精品999在线_欧美绝顶高潮抽搐喷水_久久精品成人免费网站_晚上一个人看的免费电影_国产又色又爽无遮挡免费看_成人国产av品久久久

    1. <dd id="lgp98"></dd>
      • <dd id="lgp98"></dd>
        1. 產(chǎn)品展廳收藏該商鋪

          您好 登錄 注冊

          當(dāng)前位置:
          世聯(lián)博研(北京)科技有限公司>>VaxArray效價測試測試分析系統(tǒng)>>VaxArray新型流感疫苗效價測試測試分析系統(tǒng)>>VaxArray® Platformvaxarray流感效力測試分析系統(tǒng)

          vaxarray流感效力測試分析系統(tǒng)

          返回列表頁
          • vaxarray流感效力測試分析系統(tǒng)

          收藏
          舉報
          參考價 面議
          具體成交價以合同協(xié)議為準(zhǔn)
          • 型號 VaxArray® Platform
          • 品牌 其他品牌
          • 廠商性質(zhì) 代理商
          • 所在地 北京市

          在線詢價 收藏產(chǎn)品 加入對比 查看聯(lián)系電話

          更新時間:2019-10-06 22:39:44瀏覽次數(shù):867

          聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!

          產(chǎn)品簡介

          產(chǎn)地類別 進口 應(yīng)用領(lǐng)域 醫(yī)療衛(wèi)生,生物產(chǎn)業(yè)
          vaxarray流感效力測試分析系統(tǒng)vaxarray平臺能夠在新型流感疫苗生產(chǎn)平臺中優(yōu)化疫苗的生物過程,該公司計劃在這一成功的基礎(chǔ)上積極拓展新的應(yīng)用途徑,盡可能降低生產(chǎn)公共衛(wèi)生疫苗和生物治療藥物的復(fù)雜性、執(zhí)行時間和成本。

          詳細介紹

          vaxarray流感效力測試分析系統(tǒng)

          vaxarray流感效力測試分析系統(tǒng)

          indevr的vaxarray平臺能夠在新型流感疫苗生產(chǎn)平臺中優(yōu)化疫苗的生物過程,該公司計劃在這一成功的基礎(chǔ)上積極拓展新的應(yīng)用途徑,盡可能降低生產(chǎn)公共衛(wèi)生疫苗和生物治療藥物的復(fù)雜性、執(zhí)行時間和成本。

           

          The VaxArray® Platform

          Simplify & Accelerate Potency Testing

          The VaxArray Influenza Potency test is 24x faster and 100x more sensitive than SRID. In contrast to SRID, these test kits are available for year-round use – even prior to reference reagent availability. The easy-to-use test kits are based on multiplexed sandwich immunoassays that accurately quantify the potency of influenza vaccines within 2 hours. The test kits rely on broadly reactive yet subtype specific monoclonal antibodies in a microarray format. This innovative multiplexed system enables simultaneous analysis of multiple antigens within vaccines, significantly reducing cost and testing time. VaxArray reagent kits are manufactured under cGMP conditions within ISO 13485:2016 certified facilities. The operational software is 21 CFR Part 11 +Annex compatible.

          The VaxArray® Influenza Seasonal Neuraminidase (NA) Potency Test Kit contains 32 microarrays and most of the reagents needed to quantify N1, N2, and B NA from both B/Yamagata-like and B/Victoria-like viruses. The test is a multiplexed immunoassay in which a panel of monoclonal antibodies is used to capture subtype-specific antigen. Readout is based on fluorescence from an antigen-specific “label” antibody conjugated with a proprietary fluorophore. The arrangement of monoclonal capture antibodies within each microarray (i.e., within each well) is shown in the figure below.

          Assay features include:

          • Subtype Specific and Multiplexed. Quantify any or all components of a quadrivalent formulation (note that B NA has not diverged for the two HA lineages). The microarray utilizes multiple antibodies for each subtype with 9 replicates per antibody in a single test, providing high confidence in results for protein quantification.
          • Excellent Correlation with Enzymatic Activity. Each antibody within the microarray has been shown to exhibit excellent correlation with enzymatic activity, including after forced thermal degradation.
          • Most Robust than Activity Assays.  No need for finicky enzymes, the assay is conducted at room temperature and the quantification range is generally 10-100x larger than the typical range for enzymatic activity assays.
          • Stability Indicating. The test has been demonstrated to quantify biologically relevant forms of NA.
          • Compatibility with Adjuvants. NA quantification is robust even in the presence of common adjuvants at dose-sparing antigen concentrations.
          • Off-the-Shelf Kit. Eliminates need for in-house preparation of plates or gels; streamlines testing.
          • Fast & High Throughput.  With a turn-around time of <2 hours, a single analyst can easily quantify 48 samples in a half day.
          • Automated Image and Data Processing. Software developed with FDA 21 CFR Part 11 + EU Annex 11 compatible features reduces time spent processing data, enables straightforward data integrity compliance, and maintains digital records with audit log traceability.

           

          Please refer to the Literature tab for links to scientific publications as well as application and technical notes. 

           

           

           

           

           

          收藏該商鋪

          登錄 后再收藏

          提示

          您的留言已提交成功!我們將在第一時間回復(fù)您~

          對比框

          產(chǎn)品對比 產(chǎn)品對比 聯(lián)系電話 二維碼 意見反饋 在線交流

          掃一掃訪問手機商鋪
          86-010-67529703
          在線留言
          绵阳市| 嘉禾县| 永济市| 四平市| 方正县| 莆田市| 东阳市| 西平县| 海口市| 旺苍县| 紫阳县| 绍兴市| 盘山县| 缙云县| 年辖:市辖区| 虹口区| 苗栗市| 商南县| 桐庐县| 固原市| 海淀区| 新竹市| 岗巴县| 正定县| 漳平市| 缙云县| 嘉义市| 合川市| 澄迈县| 北宁市| 德庆县| 陇西县| 光泽县| 湟中县| 镇雄县| 海伦市| 台南市| 邛崃市| 乌恰县| 开远市| 西和县|